Article info

Download PDFPDF
Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema

Authors

  1. Correspondence to Dr Claus Zehetner, Department of Ophthalmology, Medical University Innsbruck, Anichstr. 35, Innsbruck 6020, Austria; claus.zehetner{at}i-med.ac.at
View Full Text

Citation

Zehetner C, Kirchmair R, Huber S, et al
Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema

Publication history

  • Received August 4, 2012
  • Revised November 29, 2012
  • Accepted January 11, 2013
  • First published February 5, 2013.
Online issue publication 
March 17, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.